Skip to main content
Figure 1 | Nutrition Journal

Figure 1

From: Bioactive properties and clinical safety of a novel milk protein peptide

Figure 1

Determination of tyrosine kinase inhibitory properties of novel milk peptide mixture MP. The novel milk peptide mixture was screened against a panel of kinases. Specifically, the IC50 for inhibition of epidermal growth factor receptor (EGFR), insulin receptor (IR), and vascular epidermal growth factor receptor-2 (VEGFR2) were determined using a 10-point dose response radiolabeled assay.

Back to article page
\